Clinical parameters | Uni-variate | Multi-variate | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Pathological stage ((III + IV)/(I + II)) | 0.704 (0.332–1.491) | 0.359 | 0.978 (0.424–2.258) | 0.958 |
Intensity of infiltrating CD8+T cells (high/low) | 0.401 (0.190–0.843) | 0.016 | 0.403 (0.149–1.086) | 0.072 |
Intensity of infiltrating CD103+ cells (high/low) | 1.129 (0.421–1.861) | 0.786 | 1.559 (0.607–4.005) | 0.357 |
Intensity of infiltrating CD103+CD8+T cells (high/low) | 0.472 (0.224–0.994) | 0.050 | 0.452 (0.140–1.462) | 0.185 |
Ratio of CD103+CD8+T cells over total CD8+T cells (high/low) | 0.542 (0.258–1.142) | 0.107 | 1.424 (0.468–4.336) | 0.533 |